Olon

Olon is a global leader in the development and manufacturing of active pharmaceutical ingredients (APIs), serving both contract development/manufacturing organization (CDMO) partners and the generics market. The company operates 11 manufacturing facilities worldwide with expertise spanning chemical synthesis, microbial fermentation, high-potency APIs, proteins/enzymes production, and more. It supports projects from early-phase development through to commercial scale-up under full cGMP compliance. Recent investments include new HPAPI suites in the US and expanded protein production capacity in Italy. Clinical results are not applicable as Olon does not develop its own therapeutics but manufactures APIs/intermediates for client programs.